Bempedoic Acid Pregnancy Surveillance Program

Recruiting now

Conditions studied: Pregnancy, Hyperlipidemias

In brief

Bempedoic acid pregnancy surveillance program

Key facts

Study ID

NCT05103254

Run by

Esperion Therapeutics, Inc.

People needed

20

Starts

2021-09-01

Expected to finish

2032-05-01

Last updated by the study team

2024-05-17

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Exposure to at least 1 dose of bempedoic acid or bempedoic acid/ezetimibe FCDP at any time during pregnancy (from first day of last menstrual period [LMP] to pregnancy outcome

Where it is running

• Evidera, PPD business unit — Morrisville, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.